Bowton, David L <br/><br/>
Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.  [electronic resource] 

 -  The Journal of asthma : official journal of the Association for the Care of Asthma  Feb 2005 
 - 65-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0277-0903 
<br/><br/><label>Standard No.: </label>10.1081/jas-200044748  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--therapeutic use<br/>Administration, Inhalation<br/>Adult<br/>Asthma--diagnosis<br/>Bronchial Provocation Tests<br/>Bronchoconstriction--drug effects<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Humans<br/>Indoles--therapeutic use<br/>Keto Acids<br/>Male<br/>Phospholipases A--antagonists & inhibitors<br/>Phospholipases A2<br/>Skin Tests